Close
  Indian J Med Microbiol
 

Figure 3: (a) Lower overall survival (OS) among patients with SUVmax ≥ 12.55, when compared to those with SUVmax <12.55 (P = 0.1246). (b) Significantly lower OS among patients with MTV ≥38.76 ml, when compared to those MTV <38.76 ml (P = 0.0150). (c) Significantly lower OS among patients with TLG ≥301.69 ml, when compared to those with TLG <301.69 ml (P = 0.0046)

Figure 3: (a) Lower overall survival (OS) among patients with SUVmax ≥ 12.55, when compared to those with SUVmax <12.55 (<i>P</i> = 0.1246). (b) Significantly lower OS among patients with MTV ≥38.76 ml, when compared to those MTV <38.76 ml (<i>P</i> = 0.0150). (c) Significantly lower OS among patients with TLG ≥301.69 ml, when compared to those with TLG <301.69 ml (<i>P</i> = 0.0046)